Drugs / RELENOPRIDE
RELENOPRIDE
also known as
YKP10811 · Relenoprida · RELENOPRIDE HYDROCHLORIDE · YKP-10811 HYDROCHLORIDE · YKP10811*HCl
Small molecule targets HTR4 via activation
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02082457 | Dec 2013 → Dec 2014 | constipation disorder, irritable bowel syndrome | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT01989234 | Oct 2013 → Sep 2014 | constipation disorder | SK Life Science, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01523184 Comparator | Mar 2012 → Nov 2013 | constipation disorder | SK Life Science, Inc. | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RELENOPRIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3544975 ↗ |
| Known as | Relenoprida | ChEMBL registry synonym — accepted as the source's own label CHEMBL3544975 ↗ |
| Known as | RELENOPRIDE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3544975 ↗ |
| Known as | YKP-10811 HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3544975 ↗ |
| Known as | YKP10811 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01989234 ↗ |
| Known as | YKP10811*HCl | ChEMBL registry synonym — accepted as the source's own label CHEMBL3544975 ↗ |
| Action | Activate | “Serotonin 4 (5-HT4) receptor agonist” CHEMBL3544975 ↗ |
| Modality | Small molecule | — CHEMBL3544975 ↗ |
| Route | Oral | “multiple oral doses of YKP10811 or matching placebo” NCT01523184 ↗ |
| Target | HTR4 | “Serotonin 4 (5-HT4) receptor agonist” CHEMBL3544975 ↗ |